ArticleFrontiers in oncology2021

Rapamycin Antagonizes BCRP-Mediated Drug Resistance Through the PI3K/Akt/mTOR Signaling Pathway in mPRα-Positive Breast Cancer.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.